DataPile investor atlas

Angel investors & venture capitalists in Indiana, United States

Last updated 25-10-2025. Data refreshed weekly.

3 Matches for your filters
16 Total investors in region
3,050 Profiles tracked nationwide
16 Based in Indiana
Indianapolis (6) Largest investor hub
Eli Lilly and Company, Samtec Inc Notable firms

Refine investor results

Toggle multiple filters to narrow the directory instantly.

Location

States & regions

Cities

Industry focus

We found 3 investors matching "Eli Lilly and Company".

Market intelligence

  • Most active investment themes in Indiana, United States: venture capital & private equity, electrical, electronic manufacturing.
  • 6 profiles are headquartered in Indianapolis, making it the busiest hub in Indiana, United States.
  • Featured firms include Eli Lilly and Company, Samtec Inc, Miles Ahead, American Water.

Explore states in United States

Showing 1 – 3 of 3 investors

Marc Kemen profile photo Eli Lilly and Company logo
Marc Kemen
Senior Director - Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Mike Sprengnether profile photo Eli Lilly and Company logo
Mike Sprengnether
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals
Susan Hedglin profile photo Eli Lilly and Company logo
Susan Hedglin
Senior Director, Investor Relations
Eli Lilly and Company
Focus areas
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
Location
Indianapolis, Indiana, United States
Signals

Explore other regions in United States